This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Contraceptives Market

Market Insights on Contraceptives covering sales outlook, demand forecast & up-to-date key trends

Contraceptives Market by Product, Gender, End User & Region - Forecast 2022 – 2032

Contraceptives Market Outlook (2022-2032)

[200 Pages Report] The global contraceptives market is expected to reach a valuation of US$ 18 Bn in 2022. Demand for contraceptive drugs and devices is slated to surge at a 5.5% CAGR, with the total market size reaching US$ 30.8 Bn by 2032. According to a recent study by Future Market Insights (FMI), devices are leading the market in terms of product, with a share of about 58.3% in 2021.

Market Outlook:

Data Points

Market Insights

Contraceptives Market Base Year Value (2021)

US$ 17.3 Bn

Estimated Market Size (2022)

US$ 18.0 Bn

Projected Market Valuation (2032)

US$ 30.8 Bn

Value-based CAGR (2022-2032)

5.5%

Market Share of Top 5 Countries

53.3%

The market value for contraceptives was approximately 43.1% of the overall US$ 40 Bn of the global sexual wellness market in 2021.

Demand for contraceptives is increasing due to the rising need for the prevention of unplanned pregnancy. A variety of factors, including sociodemographic parameters (age, residency, religion, educational and socioeconomic position), family traits and preferences (number of surviving children, intended family size), and family planning programme exposure are expected to influence contraceptive use.

The hazards of morbidity and mortality associated with pregnancy and delivery are well known. Contraceptives have both contraceptive and non-contraceptive health advantages. Oral contraceptives, for instance, not only prevent conception but also lower the chance of ovarian and endometrial cancer, as well as ectopic pregnancies.

Customize this Report

Let us know your requirement to get
100% FREE customization

2017-2021 Contraceptives Market Historic Outlook Vs 2022-2032 Forecast

Sales of contraceptives increased at a CAGR of 3.5% from 2017 to 2021, owing to the rising need to reduce teenage pregnancies.

Early pregnancy can also cause health problems for the new born. Babies born to adolescents are likely to be underweight before and at birth and are at higher risk of neonatal mortality.

According to the Centers for Disease Control and Prevention, mortality rates among infants born to adolescents aged 15 to 19 were greatest from 2017 to 2018, with 8.8 deaths per 1,000 live births, as compared to infants born to women aged 20 and up. Preterm birth, low birth weight, and congenital deformities contributed to these deaths.

The market is driven by various initiatives taken by governments across the globe to promote awareness and accessibility to birth control methods, or family planning. For instance, USAID (the U.S. Agency for International Development) advances and aids in family planning and reproductive health programs in approximately 40 countries across the globe.

Contraceptives Market Download Report Brochure

Organizations such as the European Network, European Society of Contraception and Reproductive Health (ESC), United Nations Population Fund (UNFPA), the International Planned Parenthood Federation (IPPF), and the United States Agency for International Development (USAID) help in providing family planning guidance and adoption of WHO guidelines related to contraceptives.

According to WHO, around 842.0 million people are using contraceptive methods and 270.0 million people have an unmet need for contraception, out of 1.9 billion women of the reproductive age, globally, in 2019.

Apart from birth control, contraceptive products such as condoms can prevent the transmission of sexually transmitted infections, including HIV. For instance, according to the data provided by WHO, 37.7 million people were living with AIDS/HIV in the world in 2020. This can be reduced by using contraceptive products such as condoms.

The increasing need for contraception owing to higher awareness among the reproductive age group for birth control and family planning is expected to create opportunities for growth in the market over the forecast period.

What are the Key Opportunities for Manufacturers in the Contraceptives Market?

Sales of contraceptives are expected to rise due to the introduction of more effective male contraception products. Currently, female contraceptives are leading in the market but male contraceptives will witness high demand due to the increasing usage of male condoms.

The usage of condoms is increasing due to their dual role in both birth control and prevention of sexually transmitted diseases (STD). In addition to this, it has low to no side effects on the body.

A large number of women of reproductive age in developing countries have unmet needs, such as limited access to contraception, limited choice of methods, social and religious issues, poor quality of available services, and gender-based barriers. All these unmet needs can lead to a higher risk of unintended pregnancy.

As a result, manufacturers are aiming to expand their products and services across developing economies to improve sales.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What Factors are Restraining the Demand for Contraceptives?

Birth control drugs and devices have various side effects, such as spotting or bleeding between periods, most commonly from progestin-only pills, sore breasts, nausea, or headaches.

In rare cases, the side effects are very serious such as blood clots in the legs, heart attacks and stroke, liver disorders, and gallbladder disease. These side effects associated with the usage of contraceptives will limit sales over the forecast period.

Furthermore, lack of knowledge, misperceptions, lack of social acceptance, and exaggerated fears about the safety of contraceptive methods are major barriers to contraceptive use.

Moreover, oral contraceptives elevate the risk of heart disease. IUDs are effective contraception; however, they raise the risk of infection in some high-risk individuals. Barrier contraception is less effective than other forms of contraception, but it protects against sexually transmitted infections like HIV. Because of differences in the prevalence of the disorders implicated, the value of non-contraceptive benefits and hazards of contraceptives differs among nations.

Country-wise Insights

What is Driving the U.S. Contraceptives Market?

“Increasing Adoption of Female Condoms in the U.S. will Fuel Growth”

The U.S. dominated the North America contraceptives market, holding 92.8% of the total market share in 2021. As per the report, the trend is expected to continue over the forecast period.

The U.S. is one of the world's leading users and suppliers of contraceptives. The government has been involved in global family planning/reproductive health (FP/RH) activities for more than 50 years and is the world's largest donor in this field.

Moreover, the U.S. also increased their funding for FP/RH in the recent years. For instance, in 2020 U.S. funded approximately US$ 608.0 million for FP/RH, which includes funding for the United Nations Population Fund (UNFPA). Such initiatives are expected to bode well for the growth in the market.

Why is the Germany Contraceptives Market Considered Lucrative?

“Surging Demand for Contraceptive Devices in Germany Will Boost Growth”

Germany is set to exhibit a CAGR of nearly 5.5% in the Europe contraceptives market during the forecast period. Due to superior public health insurance, Germany is likely to be the most profitable market in the region. Birth control is covered by Germany's national health insurance for women under the age of 22.

Furthermore, contraceptive use is extremely common in the country. Due to outstanding access to online information and average availability to contraceptive supplies, Germany receives a 75.1 in the 2020 European Contraception Policy Atlas.

How is the China Contraceptives Market Faring?

“Rising Awareness Regarding Family Planning in China Will Spur Demand for Oral Contraceptives”

China accounted for about 43.4% of the East Asia contraceptives market share in 2021. Over the forecast period, demand for contraceptives is slated to grow at a 6.1% CAGR.

East & Southeast Asia and Pacific, which includes China, is expected to have the most married users (248 million), followed by Southern Asia (245.1 million), which includes India. With a rise in the number of married couples, the need for family planning comes into place.

China imported roughly 42.36 metric tonnes of hormonal contraceptive preparations in February 2022, up from just 5.28 metric tonnes the previous year. The total value of hormonal contraceptives imported in that month was 218.5 million yuan.

Better education and awareness among youth are also propelling the use of contraceptives in the country.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-wise Insights

Which Contraceptives Product is Driving Growth in the Market?

“Adoption of Contraceptive Devices Will Steer Sales in the Market”

By product type, the devices segment held a share of 58.3% in 2021. Over the assessment period, sales in this segment will increase at a CAGR of 5.5% through 2032.

Strong government promotions and initiatives for women's and children's health are propelling the usage of contraceptive devices. Government involvement in promoting family planning and contraception, particularly in emerging economies, is a crucial factor boosting the global contraceptives market.

Which Gender is Largely in Focus within the Contraceptives Market?

“Demand for Contraceptives Among Females Will Gain Traction”

Based on gender, the female segment accounted for about 74.9% of the total market share in 2021, and is expected to hold 74.3% in 2032. Female contraceptive methods are more popular than the male contraceptives because of their higher efficiency in preventing pregnancy.

According to American Sexual Health Association, male condoms are around 84% effective in preventing pregnancy, whereas pills are 92%-97% effective, implants are 99.9% effective, and IUDs are 99% effective.

Which Sales Channel Holds Maximum Share in the Contraceptives Market?

“Sales of Contraceptives through Retail Sales to Remain High”

In terms of sales channel, the retail sales segment held around 44.3% of the total market share in 2021. As per the report, total sales in this segment will account for nearly 44.4% of the total market share in 2032.

Contraceptives are widely sold through retail pharmacies, drug stores, and supermarkets/ hypermarkets. Integration of contraceptive delivery with other development programs, community-based distribution of contraceptives and commercial retail sales will push sales in this segment over the forecast period.

Competitive Landscape

Key players in the contraceptive market are concentrating on acquisitions and collaborations, and gaining FDA approvals as the key strategies for expanding their presence in the market.

These will support market players such as Cooper Surgical, Inc., AbbVie, and Exeltis USA, Inc. to improve their product portfolio together with market penetration. Some recent developments include:

  • In December 2021, Cooper Surgical, Inc. completed the acquisition of Generate Life Sciences. This acquisition helps Cooper to improve their reproductive segment.
  • In November 2020, AbbVie announced a partnership with the American College of Obstetricians and Gynaecologists, the Endometriosis Association, Healthy Women, the International Pelvic Pain Society, GE Healthcare, and the Black Women's Health Imperative to help improve the lives of the one in ten women of reproductive age in the United States who suffer from this disease.
  • In July 2019, Exeltis USA, Inc. gained approval from US Food and Drug Administration (FDA) for Slynd™, which is an oral contraceptive tablet for preventing pregnancy.

Report Scope as per Contraceptives Industry Analysis

Attribute

Details

Forecast Period

2017-2021

Historical Data Available for

2022-2032

Market Analysis

US$ Bn for Value

Key Regions Covered

North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa

Key Countries Covered

The U.S., China, Japan, Germany, Canada, the U.K., India, South Korea, Russia, Australia, BENELUX, Spain, Indonesia, France, Italy, Brazil, Thailand, Malaysia, Mexico, GCC, Argentina, South Africa, Turkey, and New Zealand

Key Market Segments Covered

Product, Gender, End User, and Region

Key Companies Profiled

  • Bayer AG Pfizer Inc.
  • Janssen Global Services, LLC
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.
  • Mylan N.V.
  • Allergan Plc.
  • Reckitt Benckiser Group plc.
  • Veru Inc.
  • Church & Dwight Co., Inc.
  • Medisafe Distribution Inc.
  • Cooper Surgical, Inc.
  • Mayer Laboratories, Inc.
  • Pfizer Inc.
  • The Female Health Company
  • Exeltis USA, Inc.

Key Market Segments Covered in Contraceptives Industry Research

By Product:

  • Drugs
    • Oral Contraceptive Pills
    • Injectable Contraceptives
    • Topical Contraceptives
  • Devices
    • Condoms
    • Diaphragms
    • Contraceptive Sponges
    • Vaginal Rings
    • Cervical Cap
    • Subdermal Implants
    • Intra-uterine Devices
      • Copper
      • Hormonal

By Gender:

  • Female
  • Male

By End User:

  • Institutional Sales
    • Hospitals
    • Specialty Clinics
  • Retail Sales
    • Retail Pharmacy
    • Drug Stores
    • Supermarkets/ Hypermarkets
  • Online Sales

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

Frequently Asked Questions

The global contraceptives market is projected to total US$ 18 Bn in 2022 and is set to expand 1.7X over the next ten years.

The contraceptives market is expected to reach US$ 30.8 Bn by 2032, with sales growing at a 5.5% CAGR.

Increasing rate of sexually transmitted diseases, the rise in the use of oral pills among teenagers, and rising government initiatives to promote maternal and child health, are some of the key trends in this market.

The U.S., China, India, Japan, and South Korea are expected to drive demand for the contraceptives industry.

North America is one of the key markets for contraceptives, with the U.S. expected to account for over 93.0% of the North American market in the year 2032.

Demand for contraceptives in Europe is expected to register growth of 5.4% over the next ten years.

The U.S., China and the U.K. are key producers of contraceptives products.

Bayer AG Pfizer Inc., Janssen Global Services, LLC, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mylan N.V., Allergan Plc., Reckitt Benckiser Group plc, Veru Inc., Church & Dwight Co., Inc., Medisafe Distribution Inc., Cooper Surgical, Inc., Mayer Laboratories, Inc., Pfizer Inc., The Female Health Company, and Exeltis USA, Inc. are the key exporters of contraceptives market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Value Added Insights

    4.1. New Product Launches

    4.2. New Technologies

    4.3. Guidelines, Regulations and Reimbursement

    4.4. Assessment of Unmet Needs

    4.5. PESTEL Analysis

    4.6. Porter’s Analysis

5. COVID-19 Crisis Analysis

        5.1.1. Current COVID-19 Statistics and Probable Future Impact

        5.1.2. COVID-19 and Impact Analysis

        5.1.3. Revenue by Product

        5.1.4. Revenue by Gender

        5.1.5. Revenue by End User

        5.1.6. Revenue by Region

6. Market Background

    6.1. Macro-Economic Factors

        6.1.1. Global GDP Outlook

        6.1.2. Global Healthcare Spending Outlook

        6.1.3. Global Pharmaceutical Outlook

    6.2. Forecast Factors - Relevance & Impact

        6.2.1. Adoption rate of Contraceptives

        6.2.2. Rising Awareness Regarding Female Reproductive Health

        6.2.3. Strategic Collaborations

        6.2.4. Rising Reproductive Age Population

        6.2.5. Rise of Healthcare Spending in Developing Economies

        6.2.6. Frequency of Product Launches

        6.2.7. Rise in Teenage Pregnancies

        6.2.8. Growing Number of Product Manufacturers

    6.3. Market Dynamics

        6.3.1. Drivers

        6.3.2. Restraints

        6.3.3. Opportunity Analysis

7. Global Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032

    7.1. Historical Market Volume (Units) Analysis, 2017–2021

    7.2. Current and Future Market Volume (Units) Projections, 2022–2032

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global Contraceptives Market - Pricing Analysis

    8.1. Regional Pricing Analysis By Product Type

    8.2. Pricing Break-up

        8.2.1. Manufacturer Level Pricing

        8.2.2. Distributor Level Pricing

    8.3. Global Average Pricing Analysis Benchmark

9. Global Contraceptives Market Demand (in Value or Size in US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032

    9.1. Historical Market Value (US$ Mn) Analysis, 2017–2021

    9.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032, by Product

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Volume Analysis By Product, 2017–2021

    10.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product, 2022–2032

        10.3.1. Drugs

            10.3.1.1. Oral Contraceptive Pills

            10.3.1.2. Injectable Contraceptives

            10.3.1.3. Topical Contraceptives

        10.3.2. Devices

            10.3.2.1. Condoms

            10.3.2.2. Diaphragms

            10.3.2.3. Contraceptive Sponges

            10.3.2.4. Vaginal Rings

            10.3.2.5. Cervical Cap

            10.3.2.6. Subdermal Implants

            10.3.2.7. Intra-uterine Devices

                10.3.2.7.1. Copper

                10.3.2.7.2. Hormonal

    10.4. Market Attractiveness Analysis By Product

11. Global Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032, by Gender

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn), By Gender, 2017–2021

    11.3. Current and Future Market Size (US$ Mn) and Forecast By Gender, 2022–2032

        11.3.1. Female

        11.3.2. Male

    11.4. Market Attractiveness Analysis By Gender

12. Global Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032, by End User

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn), By End User, 2017–2021

    12.3. Current and Future Market Size (US$ Mn) Forecast By End User, 2022–2032

        12.3.1. Institutional Sales

            12.3.1.1. Hospitals

            12.3.1.2. Specialty Clinics

        12.3.2. Retail Sales

            12.3.2.1. Retail Pharmacy

            12.3.2.2. Drug Stores

            12.3.2.3. Supermarkets/ Hypermarkets

        12.3.3. Online Sales

    12.4. Market Attractiveness Analysis By End User

13. Global Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2017–2021

    13.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2022–2032

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. East Asia

        13.3.5. South Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017–2021

    14.4. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022–2032

        14.4.1. By Country

            14.4.1.1. U.S.

            14.4.1.2. Canada

        14.4.2. By Product

        14.4.3. By Gender

        14.4.4. By End User

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Product

        14.5.3. By Gender

        14.5.4. By End User

    14.6. Market Trends

    14.7. Key Market Participants - Intensity Mapping

    14.8. Drivers and Restraints - Impact Analysis

    14.9. Country Level Analysis & Forecast

        14.9.1. U.S. Contraceptives Market Analysis

            14.9.1.1. .Introduction

            14.9.1.2. Market Analysis and Forecast by Market Taxonomy

                14.9.1.2.1. By Product

                14.9.1.2.2. By Gender

                14.9.1.2.3. By End User

        14.9.2. Canada Contraceptives Market Analysis

            14.9.2.1. Introduction

            14.9.2.2. Market Analysis and Forecast by Market Taxonomy

                14.9.2.2.1. By Product

                14.9.2.2.2. By Gender

                14.9.2.2.3. By End User

15. Latin America Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017–2021

    15.4. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022–2032

        15.4.1.  By Country

            15.4.1.1. Mexico

            15.4.1.2. Brazil

            15.4.1.3. Argentina

            15.4.1.4. Rest of Latin America

        15.4.2. By Product

        15.4.3. By Gender

        15.4.4. By End User

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Product

        15.5.3. By Gender

        15.5.4. By End User

    15.6. Market Trends

    15.7. Key Market Participants - Intensity Mapping

    15.8. Drivers and Restraints - Impact Analysis

    15.9. Country Level Analysis & Forecast

        15.9.1. Mexico Contraceptives Market Analysis

            15.9.1.1. Introduction

            15.9.1.2. Market Analysis and Forecast by Market Taxonomy

                15.9.1.2.1. By Product

                15.9.1.2.2. By Gender

                15.9.1.2.3. By End User

        15.9.2. Brazil Contraceptives Market Analysis

            15.9.2.1. Introduction

            15.9.2.2. Market Analysis and Forecast by Market Taxonomy

                15.9.2.2.1. By Product

                15.9.2.2.2. By Gender

                15.9.2.2.3. By End User

        15.9.3. Argentina Contraceptives Market Analysis

            15.9.3.1. Introduction

            15.9.3.2. Market Analysis and Forecast by Market Taxonomy

                15.9.3.2.1. By Product

                15.9.3.2.2. By Gender

                15.9.3.2.3. By End User

16. Europe Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017–2021

    16.4. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022–2032

        16.4.1.  By Country

            16.4.1.1. Germany

            16.4.1.2. Italy

            16.4.1.3. France

            16.4.1.4. U.K.

            16.4.1.5. Spain

            16.4.1.6. BENELUX

            16.4.1.7. Nordic Countries

            16.4.1.8. Russia

            16.4.1.9. Rest of Europe

        16.4.2. By Product

        16.4.3. By Gender

        16.4.4. By End User

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Product

        16.5.3. By Gender

        16.5.4. By End User

    16.6. Market Trends

    16.7. Key Market Participants - Intensity Mapping

    16.8. Drivers and Restraints - Impact Analysis

    16.9. Country Level Analysis & Forecast

        16.9.1. Germany Contraceptives Market Analysis

            16.9.1.1. Introduction

            16.9.1.2. Market Analysis and Forecast by Market Taxonomy

                16.9.1.2.1. By Product

                16.9.1.2.2. By Gender

                16.9.1.2.3. By End User

        16.9.2. Italy Contraceptives Market Analysis

            16.9.2.1. Introduction

            16.9.2.2. Market Analysis and Forecast by Market Taxonomy

                16.9.2.2.1. By Product

                16.9.2.2.2. By Gender

                16.9.2.2.3. By End User

        16.9.3. France Contraceptives Market Analysis

            16.9.3.1. Introduction

            16.9.3.2. Market Analysis and Forecast by Market Taxonomy

                16.9.3.2.1. By Product

                16.9.3.2.2. By Gender

                16.9.3.2.3. By End User

        16.9.4. U.K. Contraceptives Market Analysis

            16.9.4.1. Introduction

            16.9.4.2. Market Analysis and Forecast by Market Taxonomy

                16.9.4.2.1. By Product

                16.9.4.2.2. By Gender

                16.9.4.2.3. By End User

        16.9.5. Spain Contraceptives Market Analysis

            16.9.5.1. Introduction

            16.9.5.2. Market Analysis and Forecast by Market Taxonomy

                16.9.5.2.1. By Product

                16.9.5.2.2. By Gender

                16.9.5.2.3. By End User

        16.9.6. BENELUX Contraceptives Market Analysis

            16.9.6.1. Introduction

            16.9.6.2. Market Analysis and Forecast by Market Taxonomy

                16.9.6.2.1. By Product

                16.9.6.2.2. By Gender

                16.9.6.2.3. By End User

        16.9.7. Nordic Countries & Russia Contraceptives Market Analysis

            16.9.7.1. Introduction

            16.9.7.2. Market Analysis and Forecast by Market Taxonomy

                16.9.7.2.1. By Product

                16.9.7.2.2. By Gender

                16.9.7.2.3. By End User

        16.9.8. Russia Contraceptives Market Analysis

            16.9.8.1. Introduction

            16.9.8.2. Market Analysis and Forecast by Market Taxonomy

                16.9.8.2.1. By Product

                16.9.8.2.2. By Gender

                16.9.8.2.3. By End User

17. East Asia Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017–2021

    17.4. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022–2032

        17.4.1. By Country

            17.4.1.1. China

            17.4.1.2. Japan

            17.4.1.3. South Korea

        17.4.2. By Product

        17.4.3. By Gender

        17.4.4. By End User

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Product

        17.5.3. By Gender

        17.5.4. By End User

    17.6. Market Trends

    17.7. Key Market Participants - Intensity Mapping

    17.8. Drivers and Restraints - Impact Analysis

    17.9. Country Level Analysis & Forecast

        17.9.1. China Contraceptives Market Analysis

            17.9.1.1. Introduction

            17.9.1.2. Market Analysis and Forecast by Market Taxonomy

                17.9.1.2.1. By Product

                17.9.1.2.2. By Gender

                17.9.1.2.3. By End User

        17.9.2. Japan Contraceptives Market Analysis

            17.9.2.1. Introduction

            17.9.2.2. Market Analysis and Forecast by Market Taxonomy

                17.9.2.2.1. By Product

                17.9.2.2.2. By Gender

                17.9.2.2.3. By End User

        17.9.3. South Korea Contraceptives Market Analysis

            17.9.3.1. Introduction

            17.9.3.2. Market Analysis and Forecast by Market Taxonomy

                17.9.3.2.1. By Product

                17.9.3.2.2. By Gender

                17.9.3.2.3. By End User

18. South Asia Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032

    18.1. Introduction

    18.2. Pricing Analysis

    18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017–2021

    18.4. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022–2032

        18.4.1.  By Country

            18.4.1.1. India

            18.4.1.2. Indonesia

            18.4.1.3. Malaysia

            18.4.1.4. Philippines

            18.4.1.5. Thailand

            18.4.1.6. Vietnam

            18.4.1.7. Rest of South Asia

        18.4.2. By Product

        18.4.3. By Gender

        18.4.4. By End User

    18.5. Market Attractiveness Analysis

        18.5.1. By Country

        18.5.2. By Product

        18.5.3. By Gender

        18.5.4. By End User

    18.6. Market Trends

    18.7. Key Market Participants - Intensity Mapping

    18.8. Drivers and Restraints - Impact Analysis

    18.9. Country Level Analysis & Forecast

        18.9.1. India Contraceptives Market Analysis

            18.9.1.1. Introduction

            18.9.1.2. Market Analysis and Forecast by Market Taxonomy

                18.9.1.2.1. By Product

                18.9.1.2.2. By Gender

                18.9.1.2.3. By End User

        18.9.2. Indonesia Contraceptives Market Analysis

            18.9.2.1. Introduction

            18.9.2.2. Market Analysis and Forecast by Market Taxonomy

                18.9.2.2.1. By Product

                18.9.2.2.2. By Gender

                18.9.2.2.3. By End User

        18.9.3. Malaysia Contraceptives Market Analysis

            18.9.3.1. Introduction

            18.9.3.2. Market Analysis and Forecast by Market Taxonomy

                18.9.3.2.1. By Product

                18.9.3.2.2. By Gender

                18.9.3.2.3. By End User

        18.9.4. Philippines Contraceptives Market Analysis

            18.9.4.1. Introduction

            18.9.4.2. Market Analysis and Forecast by Market Taxonomy

                18.9.4.2.1. By Product

                18.9.4.2.2. By Gender

                18.9.4.2.3. By End User

        18.9.5. Thailand Contraceptives Market Analysis

            18.9.5.1. Introduction

            18.9.5.2. Market Analysis and Forecast by Market Taxonomy

                18.9.5.2.1. By Product

                18.9.5.2.2. By Gender

                18.9.5.2.3. By End User

        18.9.6. Vietnam Contraceptives Market Analysis

            18.9.6.1. Introduction

            18.9.6.2. Market Analysis and Forecast by Market Taxonomy

                18.9.6.2.1. By Product

                18.9.6.2.2. By Gender

                18.9.6.2.3. By End User

                18.9.6.2.4.

        18.9.7. Rest of South Asia Contraceptives Market Analysis

            18.9.7.1. Introduction

            18.9.7.2. Market Analysis and Forecast by Market Taxonomy

                18.9.7.2.1. By Product

                18.9.7.2.2. By Gender

                18.9.7.2.3. By End User

19. Oceania Contraceptives Market 2017-2021 and Forecast 2022-2032

    19.1. Introduction

    19.2. Pricing Analysis

    19.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017–2021

    19.4. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022–2032

        19.4.1. By Country

            19.4.1.1. Australia

            19.4.1.2. New Zealand

        19.4.2. By Product

        19.4.3. By Gender

        19.4.4. By End User

    19.5. Market Attractiveness Analysis

        19.5.1. By Country

        19.5.2. By Product

        19.5.3. By Gender

        19.5.4. By End User

    19.6. Key Market Participants - Intensity Mapping

    19.7. Drivers and Restraints - Impact Analysis

    19.8. Country Level Analysis & Forecast

        19.8.1. Australia Contraceptives Market Analysis

            19.8.1.1. Introduction

            19.8.1.2. Market Analysis and Forecast by Market Taxonomy

                19.8.1.2.1. By Product

                19.8.1.2.2. By Gender

                19.8.1.2.3. By End User

        19.8.2. New Zealand Contraceptives Market Analysis

            19.8.2.1. Introduction

            19.8.2.2. Market Analysis and Forecast by Market Taxonomy

                19.8.2.2.1. By Product

                19.8.2.2.2. By Gender

                19.8.2.2.3. By End User

20. Middle East and Africa (MEA) Contraceptives Market Analysis 2017–2021 and Forecast 2022–2032

    20.1. Introduction

    20.2. Pricing Analysis

    20.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2017–2021

    20.4. Current and Future Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2022–2032

        20.4.1.  By Country

            20.4.1.1. GCC Countries

            20.4.1.2. Israel

            20.4.1.3. Turkey

            20.4.1.4. South Africa & North Africa

            20.4.1.5. Rest of Middle East and Africa

        20.4.2. By Product

        20.4.3. By Gender

        20.4.4. By End User

    20.5. Market Attractiveness Analysis

        20.5.1. By Country

        20.5.2. By Product

        20.5.3. By Gender

        20.5.4. By End User

    20.6. Market Trends

    20.7. Key Market Participants - Intensity Mapping

    20.8. Drivers and Restraints - Impact Analysis

    20.9. Country Level Analysis & Forecast

        20.9.1. GCC Countries Contraceptives Market Analysis

            20.9.1.1. Introduction

            20.9.1.2. Market Analysis and Forecast by Market Taxonomy

                20.9.1.2.1. By Product

                20.9.1.2.2. By Gender

                20.9.1.2.3. By End User

        20.9.2. Israel Contraceptives Market Analysis

            20.9.2.1. Introduction

            20.9.2.2. Market Analysis and Forecast by Market Taxonomy

                20.9.2.2.1. By Product

                20.9.2.2.2. By Gender

                20.9.2.2.3. By End User

        20.9.3. Turkey Contraceptives Market Analysis

            20.9.3.1. Introduction

            20.9.3.2. Market Analysis and Forecast by Market Taxonomy

                20.9.3.2.1. By Product

                20.9.3.2.2. By Gender

                20.9.3.2.3. By End User

        20.9.4. South Africa & North Africa Contraceptives Market Analysis

            20.9.4.1. Introduction

            20.9.4.2. Market Analysis and Forecast by Market Taxonomy

                20.9.4.2.1. By Product

                20.9.4.2.2. By Gender

                20.9.4.2.3. By End User

        20.9.5. Rest of MEA Contraceptives Market Analysis

            20.9.5.1. Introduction

            20.9.5.2. Market Analysis and Forecast by Market Taxonomy

                20.9.5.2.1. By Product

                20.9.5.2.2. By Gender

                20.9.5.2.3. By End User

21. Market Structure Analysis

    21.1. Market Analysis by Tier of Companies

    21.2. Market Share Analysis of Top Players

    21.3. Market Presence Analysis

22. Competition Analysis

    22.1. Competition Dashboard

    22.2. Competition Benchmarking

    22.3. Competition Deep Dive

        22.3.1. Bayer AG Pfizer Inc.

            22.3.1.1. Overview

            22.3.1.2. Product Portfolio

            22.3.1.3. SWOT Analysis

            22.3.1.4. Sales Footprint

            22.3.1.5. Strategy Overview

            22.3.1.6. Key financials

        22.3.2. Janssen Global Product, LLC

            22.3.2.1. Overview

            22.3.2.2. Product Portfolio

            22.3.2.3. SWOT Analysis

            22.3.2.4. Sales Footprint

            22.3.2.5. Strategy Overview

            22.3.2.6. Key financials

        22.3.3. Teva Pharmaceutical Industries Ltd.

            22.3.3.1. Overview

            22.3.3.2. Product Portfolio

            22.3.3.3. SWOT Analysis

            22.3.3.4. Sales Footprint

            22.3.3.5. Strategy Overview

            22.3.3.6. Key financials

        22.3.4. Merck & Co., Inc.

            22.3.4.1. Overview

            22.3.4.2. Product Portfolio

            22.3.4.3. SWOT Analysis

            22.3.4.4. Sales Footprint

            22.3.4.5. Strategy Overview

            22.3.4.6. Key financials

        22.3.5. Mylan N.V.

            22.3.5.1. Overview

            22.3.5.2. Product Portfolio

            22.3.5.3. SWOT Analysis

            22.3.5.4. Sales Footprint

            22.3.5.5. Strategy Overview

            22.3.5.6. Key financials

        22.3.6. Allergan Plc.

            22.3.6.1. Overview

            22.3.6.2. Product Portfolio

            22.3.6.3. SWOT Analysis

            22.3.6.4. Sales Footprint

            22.3.6.5. Strategy Overview

            22.3.6.6. Key financials

        22.3.7. Reckitt Benckiser Group plc.

            22.3.7.1. Overview

            22.3.7.2. Product Portfolio

            22.3.7.3. SWOT Analysis

            22.3.7.4. Sales Footprint

            22.3.7.5. Strategy Overview

            22.3.7.6. Key financials

        22.3.8. Veru Inc.

            22.3.8.1. Overview

            22.3.8.2. Product Portfolio

            22.3.8.3. SWOT Analysis

            22.3.8.4. Sales Footprint

            22.3.8.5. Strategy Overview

            22.3.8.6. Key financials

        22.3.9. Church & Dwight Co., Inc.

            22.3.9.1. Overview

            22.3.9.2. Product Portfolio

            22.3.9.3. SWOT Analysis

            22.3.9.4. Sales Footprint

            22.3.9.5. Strategy Overview

            22.3.9.6. Key financials

        22.3.10. Medisafe Distribution Inc.

            22.3.10.1. Overview

            22.3.10.2. Product Portfolio

            22.3.10.3. SWOT Analysis

            22.3.10.4. Sales Footprint

            22.3.10.5. Strategy Overview

            22.3.10.6. Key financials

        22.3.11. Cooper Surgical, Inc.

            22.3.11.1. Overview

            22.3.11.2. Product Portfolio

            22.3.11.3. SWOT Analysis

            22.3.11.4. Sales Footprint

            22.3.11.5. Strategy Overview

            22.3.11.6. Key financials

        22.3.12. Mayer Laboratories, Inc.

            22.3.12.1. Overview

            22.3.12.2. Product Portfolio

            22.3.12.3. SWOT Analysis

            22.3.12.4. Sales Footprint

            22.3.12.5. Strategy Overview

            22.3.12.6. Key financials

        22.3.13. Pfizer Inc.

            22.3.13.1. Overview

            22.3.13.2. Product Portfolio

            22.3.13.3. SWOT Analysis

            22.3.13.4. Sales Footprint

            22.3.13.5. Strategy Overview

            22.3.13.6. Key financials

        22.3.14. The Female Health Company

            22.3.14.1. Overview

            22.3.14.2. Product Portfolio

            22.3.14.3. SWOT Analysis

            22.3.14.4. Sales Footprint

            22.3.14.5. Strategy Overview

            22.3.14.6. Key financials

        22.3.15. Exeltis USA, Inc.

            22.3.15.1. Overview

            22.3.15.2. Product Portfolio

            22.3.15.3. SWOT Analysis

            22.3.15.4. Sales Footprint

            22.3.15.5. Strategy Overview

            22.3.15.6. Key financials

23. Assumptions and Acronyms Used

24. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 02: Global Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 03: Global Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender

Table 04: Global Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User

Table 05: Global Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Region

Table 06: North America Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 07: North America Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 08: North America Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 09: North America Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender

Table 10: North America Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User

Table 11: Latin America Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 12: Latin America Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 13: Latin America Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 14: Latin America Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender

Table 15: Latin America Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User

Table 16: Europe Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 17: Europe Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 18: Europe Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 19: Europe Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender

Table 20: Europe Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User

Table 21: South Asia Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 22: South Asia Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 23: South Asia Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 24: South Asia Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender

Table 25: South Asia Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User

Table 26: East Asia Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 27: East Asia Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 28: East Asia Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 29: East Asia Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender

Table 30: East Asia Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User

Table 31: Oceania Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 32: Oceania Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 33: Oceania Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 34: Oceania Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender

Table 35: Oceania Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User

Table 36: MEA Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 37: MEA Contraceptives Market Volume (Units) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 38: MEA Contraceptives Market Size (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Product

Table 39: MEA Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by Gender

Table 40: MEA Contraceptives Market Value (US$ Mn) Analysis 2017–2021 and Forecast, 2022–2032, by End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Contraceptives Market Volume (in Units) Analysis, 2017–2021

Figure 02: Global Contraceptives Market Volume (in Units) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 03: Global Average Pricing Analysis Benchmark US$ per unit (2021)

Figure 04: Mini Devices Pricing Analysis (US$) for Per Unit, by Country, 2021

Figure 05: Cone Devices Pricing Analysis (US$) for Per Unit, by Country, 2021

Figure 06: Balloon Catheter Devices Pricing Analysis (US$) for Per Unit, by Country, 2021

Figure 07: Bed Systems Pricing Analysis (US$) for Per Unit, by Country, 2021

Figure 08: Global Contraceptives Market Size (‘US$ Mn) Analysis, 2017–2021

Figure 09: Global Contraceptives Market Size (US$ Mn)) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 10: Global Contraceptives Market Absolute $ Opportunity Analysis, 2022–2032

Figure 11: Global Contraceptives Market Analysis by Product–2022 & 2032

Figure 12: Global Contraceptives Market Y-o-Y Growth Projections by Product, 2022 – 2032

Figure 13: Global Contraceptives Market Attractiveness Analysis, by Product, 2022-2032

Figure 14: Global Contraceptives Market Analysis by Gender –2022 & 2032

Figure 15: Global Contraceptives Market Y-o-Y Growth Projections by Gender, 2022 – 2032

Figure 16: Global Contraceptives Market Attractiveness Analysis, by Gender, 2022-2032

Figure 17: Global Contraceptives Market Analysis by End User –2022 & 2032

Figure 18: Global Contraceptives Market Y-o-Y Growth Projections by End User, 2022 – 2032

Figure 19: Global Contraceptives Market Attractiveness Analysis, by End User, 2022-2032

Figure 20: Global Contraceptives Market Analysis by Region –2022 & 2032

Figure 21: Global Contraceptives Market Y-o-Y Growth Projections by Region, 2022 – 2032

Figure 22: Global Contraceptives Market Attractiveness Analysis, by Region, 2022-2032

Figure 23: North America Contraceptives Market Value Share, by Country (2022 E)

Figure 24: North America Contraceptives Market Value Share, by Product (2022 E)

Figure 25: North America Contraceptives Market Value Share, by Gender (2022 E)

Figure 26: North America Contraceptives Market Value Share, by End User (2022 E)

Figure 27: North America Contraceptives Market Size (‘US$ Mn) Analysis, 2017–2021

Figure 28: North America Contraceptives Market Size (US$ Mn)) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 29: North America Contraceptives Market Attractiveness Analysis 2022-2032, by Country

Figure 30: North America Contraceptives Market Attractiveness Analysis 2022-2032, by Product

Figure 31: North America Contraceptives Market Attractiveness Analysis 2022-2032, by Gender

Figure 32: North America Contraceptives Market Attractiveness Analysis 2022-2032, by End User

Figure 33: Latin America Contraceptives Market Value Share, by Country (2022 E)

Figure 34: Latin America Contraceptives Market Value Share, by Product (2022 E)

Figure 35: Latin America Contraceptives Market Value Share, by Gender (2022 E)

Figure 36: Latin America Contraceptives Market Value Share, by End User (2022 E)

Figure 37: Latin America Contraceptives Market Size (‘US$ Mn) Analysis, 2017–2021

Figure 38: Latin America Contraceptives Market Size (US$ Mn)) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 39: Latin America Contraceptives Market Attractiveness Analysis 2022-2032, by Country

Figure 40: Latin America Contraceptives Market Attractiveness Analysis 2022-2032, by Product

Figure 41: Latin America Contraceptives Market Attractiveness Analysis 2022-2032, by Gender

Figure 42: Latin America Contraceptives Market Attractiveness Analysis 2022-2032, by End User

Figure 43: Europe Contraceptives Market Value Share, by Country (2022 E)

Figure 44: Europe Contraceptives Market Value Share, by Product (2022 E)

Figure 45: Europe Contraceptives Market Value Share, by Gender (2022 E)

Figure 46: Europe Contraceptives Market Value Share, by End User (2022 E)

Figure 47: Europe Contraceptives Market Size (‘US$ Mn) Analysis, 2017–2021

Figure 48: Europe Contraceptives Market Size (US$ Mn)) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 49: Europe Contraceptives Market Attractiveness Analysis 2022-2032, by Country

Figure 50: Europe Contraceptives Market Attractiveness Analysis 2022-2032, by Product

Figure 51: Europe Contraceptives Market Attractiveness Analysis 2022-2032, by Gender

Figure 52: Europe Contraceptives Market Attractiveness Analysis 2022-2032, by End User

Figure 53: South Asia Contraceptives Market Value Share, by Country (2022 E)

Figure 54: South Asia Contraceptives Market Value Share, by Product (2022 E)

Figure 55: South Asia Contraceptives Market Value Share, by Gender (2022 E)

Figure 56: South Asia Contraceptives Market Value Share, by End User (2022 E)

Figure 57: South Asia Contraceptives Market Size (‘US$ Mn) Analysis, 2017–2021

Figure 58: South Asia Contraceptives Market Size (US$ Mn)) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 59: South Asia Contraceptives Market Attractiveness Analysis 2022-2032, by Country

Figure 60: South Asia Contraceptives Market Attractiveness Analysis 2022-2032, by Product

Figure 61: South Asia Contraceptives Market Attractiveness Analysis 2022-2032, by Gender

Figure 62: South Asia Contraceptives Market Attractiveness Analysis 2022-2032, by End User

Figure 63: East Asia Contraceptives Market Value Share, by Country (2022 E)

Figure 64: East Asia Contraceptives Market Value Share, by Product (2022 E)

Figure 65: East Asia Contraceptives Market Value Share, by Gender (2022 E)

Figure 66: East Asia Contraceptives Market Value Share, by End User (2022 E)

Figure 67: East Asia Contraceptives Market Size (‘US$ Mn) Analysis, 2017–2021

Figure 68: East Asia Contraceptives Market Size (US$ Mn)) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 69: East Asia Contraceptives Market Attractiveness Analysis 2022-2032, by Country

Figure 70: East Asia Contraceptives Market Attractiveness Analysis 2022-2032, by Product

Figure 71: East Asia Contraceptives Market Attractiveness Analysis 2022-2032, by Gender

Figure 72: East Asia Contraceptives Market Attractiveness Analysis 2022-2032, by End User

Figure 73: Oceania Contraceptives Market Value Share, by Country (2022 E)

Figure 74: Oceania Contraceptives Market Value Share, by Product (2022 E)

Figure 75: Oceania Contraceptives Market Value Share, by Gender (2022 E)

Figure 76: Oceania Contraceptives Market Value Share, by End User (2022 E)

Figure 77: Oceania Contraceptives Market Size (‘US$ Mn) Analysis, 2017–2021

Figure 78: Oceania Contraceptives Market Size (US$ Mn)) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 79: Oceania Contraceptives Market Attractiveness Analysis 2022-2032, by Country

Figure 80: Oceania Contraceptives Market Attractiveness Analysis 2022-2032, by Product

Figure 81: Oceania Contraceptives Market Attractiveness Analysis 2022-2032, by Gender

Figure 82: Oceania Contraceptives Market Attractiveness Analysis 2022-2032, by End User

Figure 83: MEA Contraceptives Market Value Share, by Country (2022 E)

Figure 84: MEA Contraceptives Market Value Share, by Product (2022 E)

Figure 85: MEA Contraceptives Market Value Share, by Gender (2022 E)

Figure 86: MEA Contraceptives Market Value Share, by End User (2022 E)

Figure 87: MEA Contraceptives Market Size (US$ Mn) Analysis, 2017–2021

Figure 88: MEA Contraceptives Market Size (US$ Mn) & Y-o-Y Growth (%) Forecast, 2022–2032

Figure 89: MEA Contraceptives Market Attractiveness Analysis 2022-2032, by Country

Figure 90: MEA Contraceptives Market Attractiveness Analysis 2022-2032, by Product

Figure 91: MEA Contraceptives Market Attractiveness Analysis 2022-2032, by Gender

Figure 92: MEA Contraceptives Market Attractiveness Analysis 2022-2032, by End User

Figure 93: Global Contraceptives Market Value Proportion Analysis, by Countries, 2021

Figure 94: Global Contraceptives Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2022-2032

Figure 95: U.S. Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 96: U.S. Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 97: U.S. Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 98: Canada Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 99: Canada Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 100: Canada Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 101: Brazil Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 102: Brazil Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 103: Brazil Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 104: Mexico Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 105: Mexico Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 106: Mexico Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 107: Argentina Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 108: Argentina Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 109: Argentina Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 110: Germany Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 111: Germany Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 112: Germany Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 113: Italy Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 114: Italy Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 115: Italy Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 116: France Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 117: France Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 118: France Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 119: U.K. Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 120: U.K. Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 121: U.K. Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 122: Spain Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 123: Spain Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 124: Spain Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 125: BENELUX Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 126: BENELUX Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 127: BENELUX Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 128: Russia Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 129: Russia Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 130: Russia Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 131: India Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 132: India Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 133: India Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 134: Thailand Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 135: Thailand Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 136: Thailand Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 137: Indonesia Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 138: Indonesia Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 139: Indonesia Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 140: Malaysia Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 141: Malaysia Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 142: Malaysia Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 143: China Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 144: China Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 145: China Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 146: Japan Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 147: Japan Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 148: Japan Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 149: South Korea Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 150: South Korea Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 151: South Korea Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 152: Australia Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 153: Australia Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 154: Australia Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 155: New Zealand Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 156: New Zealand Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 157: New Zealand Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 158: GCC Countries Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 159: GCC Countries Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 160: GCC Countries Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 161: Turkey Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 162: Turkey Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 163: Turkey Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Figure 164: South Africa Contraceptives Market Share Analysis (%) by Product, 2022 & 2032

Figure 165: South Africa Contraceptives Market Share Analysis (%) by Gender, 2022 & 2032

Figure 166: South Africa Contraceptives Market Share Analysis (%) by End User, 2022 & 2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Wearable Pregnancy Devices Market

Published : December 2018

Healthcare

U.S. Digital Pregnancy Test Kits Market

Published : June 2021

Healthcare

Pre-Pregnancy Genetic Testing Market

Published : April 2016

Healthcare

Fertility and Pregnancy Rapid Test Kits Market

Published : February 2022

Google translate

Contraceptives Market